Home About

TL;DR CNBC


Patients regain weight after stopping Eli Lilly's Zepbound, study says - TL;DR CNBC

Patients regain weight after stopping Eli Lilly's Zepbound, study says

Publishing timestamp: 2023-12-11 16:48:22


Summary

Patients who took Eli Lilly's weight loss drug Zepbound regained around half of the weight they lost after stopping the treatment, according to new data. The study suggests that continued therapy is necessary to maintain significant weight loss. Some analysts believe Zepbound could become the best-selling drug of all time.


Sentiment: MIXED

Tickers: NOVO.B-DK,  LLY, 

Keywords: business news,  breaking news,  pharmaceuticals,  health care industry,  business,  eli lilly and co,  biotech and pharmaceuticals,  science,  biotechnology,  novo nordisk a/s, 

Source: https://www.cnbc.com/2023/12/11/zepbound-patients-on-eli-lilly-drug-regain-weight-after-stopping-it.html


Developed by Leo Phan